201 related articles for article (PubMed ID: 23400010)
1. Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
Del-Aguila JL; Beitelshees AL; Cooper-Dehoff RM; Chapman AB; Gums JG; Bailey K; Gong Y; Turner ST; Johnson JA; Boerwinkle E
Pharmacogenomics J; 2014 Feb; 14(1):35-40. PubMed ID: 23400010
[TBL] [Abstract][Full Text] [Related]
2. Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
Vandell AG; McDonough CW; Gong Y; Langaee TY; Lucas AM; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Johnson RJ; Boerwinkle E; Turner ST; Cooper-DeHoff RM; Johnson JA
J Intern Med; 2014 Nov; 276(5):486-97. PubMed ID: 24612202
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
McGill JB; Reilly PA
Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
[TBL] [Abstract][Full Text] [Related]
4. Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Duarte JD; Turner ST; Tran B; Chapman AB; Bailey KR; Gong Y; Gums JG; Langaee TY; Beitelshees AL; Cooper-Dehoff RM; Boerwinkle E; Johnson JA
Pharmacogenomics J; 2013 Jun; 13(3):257-63. PubMed ID: 22350108
[TBL] [Abstract][Full Text] [Related]
5. Genome Wide Association Study Identifies the
Singh S; McDonough CW; Gong Y; Alghamdi WA; Arwood MJ; Bargal SA; Dumeny L; Li WY; Mehanna M; Stockard B; Yang G; de Oliveira FA; Fredette NC; Shahin MH; Bailey KR; Beitelshees AL; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29523524
[TBL] [Abstract][Full Text] [Related]
6. PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
Gong Y; McDonough CW; Beitelshees AL; Karnes JH; O'Connell JR; Turner ST; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Johnson JA; Cooper-DeHoff RM
Pharmacotherapy; 2014 Feb; 34(2):123-30. PubMed ID: 24122840
[TBL] [Abstract][Full Text] [Related]
7. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
Moore MJ; Gong Y; Hou W; Hall K; Schmidt SO; Curry RW; Beitelshees AL; Chapman A; Turner ST; Schwartz GL; Bailey K; Boerwinkle E; Gums JG; Cooper-DeHoff RM; Johnson JA
Pharmacotherapy; 2014 Nov; 34(11):1132-40. PubMed ID: 25202885
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
Flack JM; Saunders E; Gradman A; Kraus WE; Lester FM; Pratt JH; Alderman M; Green S; Vargas R; Espenshade M; Ceesay P; Alexander J; Goldberg A;
Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
[TBL] [Abstract][Full Text] [Related]
9. Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide.
Del-Aguila JL; Cooper-DeHoff RM; Chapman AB; Gums JG; Beitelshees AL; Bailey K; Turner ST; Johnson JA; Boerwinkle E
Pharmacogenomics J; 2015 Apr; 15(2):153-7. PubMed ID: 25201287
[TBL] [Abstract][Full Text] [Related]
10. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
Ketelhut R; Bramlage P
Clin Drug Investig; 2010; 30(5):301-11. PubMed ID: 20384386
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
[TBL] [Abstract][Full Text] [Related]
12. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
Pool JL; Glazer R; Crikelair N; Levy D
Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
[TBL] [Abstract][Full Text] [Related]
13. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
McGill JB; Reilly PA
Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
[TBL] [Abstract][Full Text] [Related]
15. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies.
Messerli FH; Bangalore S
Am J Med; 2011 Oct; 124(10):896-9. PubMed ID: 21962309
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
Oparil S; Aurup P; Snavely D; Goldberg A
Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
[TBL] [Abstract][Full Text] [Related]
17. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
Turner ST; Boerwinkle E; O'Connell JR; Bailey KR; Gong Y; Chapman AB; McDonough CW; Beitelshees AL; Schwartz GL; Gums JG; Padmanabhan S; Hiltunen TP; Citterio L; Donner KM; Hedner T; Lanzani C; Melander O; Saarela J; Ripatti S; Wahlstrand B; Manunta P; Kontula K; Dominiczak AF; Cooper-DeHoff RM; Johnson JA
Hypertension; 2013 Aug; 62(2):391-7. PubMed ID: 23753411
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension.
Radevski IV; Valtchanova ZP; Candy GP; Hlatswayo MN; Sareli P
J Clin Pharmacol; 2000 Jul; 40(7):713-21. PubMed ID: 10883412
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
Edes I;
Clin Drug Investig; 2009; 29(5):293-304. PubMed ID: 19366271
[TBL] [Abstract][Full Text] [Related]
20. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
Rosenstock J; Rossi L; Lin CS; MacNeil D; Osbakken M
J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
